Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity
Cell Reports · 2026
DOI: 10.1016/j.celrep.2026.117910 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2026. Verfasst von Thomas Fabre und 21 weiteren Autor:innen. Beteiligte Einrichtung: Inflammation & Immunology Research Unit, Pfizer Inc., 1 Portland St., Cambridge, MA 02139, USA. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Cytokines, Neoplasms. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Inflammation & Immunology Research Unit, Pfizer Inc., 1 Portland St., Cambridge, MA 02139, USA.
- Oncology Research Division, Pfizer Inc., 10555 Science Center Dr., San Diego, CA 92121, USA.
- Biomedicine Design, Pfizer Inc., 10555 Science Center Dr., San Diego, CA 92121, USA.
- Biomedicine Design, Pfizer Inc., 1 Portland St., Cambridge, MA 02139, USA.
- Inflammation & Immunology Research Unit, Pfizer Inc., 1 Portland St., Cambridge, MA 02139, USA. Electronic address: alex.m.barron@gmail.com.
- Inflammation & Immunology Research Unit, Pfizer Inc., 1 Portland St., Cambridge, MA 02139, USA. Electronic address: richard.gieseckiii@pfizer.com.
Zitieren
APA
Fabre, T., Hendrickson, E., McGourty, K., Marcovecchio, P. M., McMahon, J., Patti, S., Cage, K., Searles, S., Widjaja, C., Stairiker, C., Bound, K., Martino, R., Pyszczynski, E., Zhang, Y., Thomas, G., Stoner, S. A., Ching, K. A., Jin, F., Dillon, C. P., …, & Gieseck, R. L. (2026). Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity. Cell Reports. https://doi.org/10.1016/j.celrep.2026.117910
Vancouver
Fabre T, Hendrickson E, McGourty K, Marcovecchio PM, McMahon J, Patti S, et al. Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity. Cell Reports. 2026. doi:10.1016/j.celrep.2026.117910
BibTeX
@article{Fabre2026,
author = {Fabre, Thomas and Hendrickson, Eleanore and McGourty, Katherine and Marcovecchio, Paola M and McMahon, James and Patti, Sara and Cage, KaiLi and Searles, Stephen and Widjaja, Christella and Stairiker, Christopher and Bound, Kathryn and Martino, Roxanne and Pyszczynski, Edward and Zhang, Ying and Thomas, Graham and Stoner, Samuel A and Ching, Keith A and Jin, Fang and Dillon, Christopher P and Wynn, Thomas A and Barron, Alexander M S and Gieseck, Richard L},
title = {Combined type 2 cytokine blockade enhances PD-1-mediated antitumor immunity},
journal = {Cell Reports},
year = {2026},
doi = {10.1016/j.celrep.2026.117910}
}
EUVIMED